Remarkably, we identified a positive correlation between myoferlin expression and both c-Met and HGF expression in cancer cells, which corroborates a strong connection between myoferlin and the HGF/c-Met pathway in ccRCC. The gene discussed is MYOF; the disease is nonpapillary renal cell carcinoma.